한글목차

세계의 멀티오믹스 시장 규모는 2024년 27억 달러에서 예측 기간 중 CAGR 13.5%로 추이하며, 2029년말에는 51억 달러 규모에 달할 것으로 예측됩니다.

소모품 부문은 2024년 16억 달러에서 CAGR 14.1%로 추이하며, 2029년말에는 31억 달러에 달할 것으로 예측됩니다. 또한 기기 부문은 2024년 6억 2,990만 달러에서 CAGR 12.4%로 추이하며, 2029년말에는 11억 달러에 달할 것으로 예측됩니다.

세계의 멀티오믹스 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 신규 기술 및 기술개발 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 개요

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 개요
• 기술 배경
• 오믹스 유형
• 다양한 멀티오믹스 어프로치와 용도
• 기술 인프라와 데이터 통합
• PESTEL 분석
• 규제 상황
• 전략적 권장사항

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 멀티오믹스 연구와 용도의 급속한 진보
• 멀티오믹스 연구에 대한 양호한 자금조달 시나리오
• DNA 시퀀싱의 가격 저하
• 암이환율의 증가에 의해 개별화 치료의 수요가 증가
• 의약품 개발 프로세스에서 멀티오믹스의 유망한 용도
• 시장 성장 억제요인
• 데이터 표준화의 결여
• 시장 기회
• 단세포 멀티오믹스 용도의 확대

제4장 신규 기술과 개발

• 멀티오믹스용 AI
• AI 멀티오믹스 시장의 기업
• 단세포 오믹스와 멀티오믹스의 진보

제5장 시장 세분화 분석

• 주요 시장 동향
• 세분화 내역
• 세계의 멀티오믹스 시장 : 제품별
• 기기
• 소모품
• 소프트웨어와 서비스
• 세계의 멀티오믹스 시장 : 플랫폼별
• 유전체학
• 단백질체학
• 전사체학
• 대사체학
• 기타
• 세계의 멀티오믹스 시장 : 용도별
• 종양
• 면역
• 신경
• 세포 생물
• 기타
• 세계의 멀티오믹스 시장 : 최종사용자별
• 학술연구기관
• 제약·바이오테크놀러지 기업
• 임상 실험실·원내 실험실
• 기타
• 지역적 내역
• 세계의 멀티오믹스 시장 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제6장 경쟁 정보

• 주요 기업 순위
• 기업의 채택 전략
• 협업과 파트너십
• 신제품의 발매
• 확장과 투자
• M&A
• 합의 사항
• 특허 분석

제7장 멀티오믹스 시장의 지속가능성 : ESG 관점

• ESG : 서론
• 시장에서의 ESG 퍼포먼스
• 멀티오믹스 업계에서의 ESG 실천
• BCC로부터의 결론

제8장 부록

• 조사 방법
• 두자어
• 참고 문헌
• 기업 개요
• AGILENT TECHNOLOGIES INC.
• BECKMAN COULTER INC.(SUBSIDIARY OF DANAHER CORP.)
• BIO-RAD LABORATORIES INC.
• BD
• BRUKER
• BGI
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• QIAGEN
• REVVITY
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.

영문목차

The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

The global market for multiomics for consumables is expected to grow from $1.6 billion in 2024 and is projected to reach $3.1 billion by the end of 2029, at a CAGR of 14.1% during the forecast period of 2024 to 2029.

The global market for multiomics for instruments is expected to grow from $629.9 million in 2024 and is projected to reach $1.1 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

Report Scope:

This report covers the global market for multiomics segments based on products, platforms, applications, end-users, and regions. This research report incorporates an in-depth analysis of the multiomics market, including market estimations and trends through 2029. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Major players, products, platforms, applications, market dynamics, and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, competitive analysis, and strategic recommendations, which will aid the companies in devising their strategic plan of action.

Report Includes:

• 51 data tables and 55 additional tables
• An analysis of the current and future global markets for multiomics
• Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the global multiomics market, with market share analysis by product, type, platform, end-user, application and region
• Discussion of the applications of multiomics in research studies such as analyzing many omics datasets, integrating data from genomes, transcriptomics, epigenetics, and proteomics. This in turn provides more precise information to identify causal alterations, and by exposing the etiology of the disease, can lead to the possible treatment options
• Discussions of the market dynamics, opportunities, and challenges, as well as emerging technologies
• Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding.
• Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., and F. Hoffman-La Roche Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background
• Omics Types
• Various Multiomics Approaches and Applications
• Technological Infrastructure and Data Integration
• PESTEL Analysis
• Political
• Economic
• Social
• Technological
• Environmental
• Legal
• Regulatory Landscape
• Federal Regulation
• CMS Regulation
• U.S. Food and Drug Administration Regulation
• U.S. Federal Trade Commission Regulation
• Strategic Recommendations

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rapid Advances in Multiomics Research and its Applications
• Favorable Funding Scenario for Multiomics Research Activities
• Decrease in DNA-Sequencing Method Prices
• Growing Prevalence of Cancer Generating Demand for Personalized Treatments
• Promising Applications of Multiomics in the Drug Development Process
• Market Restraints
• Lack of Data Standardization
• Market Opportunities
• Expanding Single-Cell Multiomics Applications

Chapter 4 Emerging Technologies and Developments

• Artificial Intelligence in Multiomics
• Companies in the Artificial Intelligence Multiomics Market
• Advances in Single-Cell Omics and Multiomics

Chapter 5 Market Segmentation Analysis

• Key Market Trends
• Segmentation Breakdown
• Global Market for Multiomics by Product
• Instruments
• Consumables
• Software and Services
• Global Market for Multiomics by Platform
• Genomics
• Proteomics
• Transcriptomics
• Metabolomics
• Other Platforms
• Global Market for Multiomics by Application
• Oncology
• Immunology
• Neurology
• Cell Biology
• Other Applications
• Global Market for Multiomics by End User
• Academic Research Organizations
• Pharmaceutical and Biotechnology Companies
• Clinical and Hospital Laboratories
• Other End Users
• Geographic Breakdown
• Global Multiomics Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Top Players Ranking
• Key Strategies Adopted by Players
• Collaborations and Partnerships
• New Product Launches
• Expansions and Investments
• Mergers and Acquisitions
• Agreements
• Patent Analysis

Chapter 7 Sustainability in Multiomics Market: ESG Perspective

• Introduction to ESG
• ESG Performance in Market
• ESG Practices in the Multiomics Industry
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Methodology
• Acronyms
• References
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
• BIO-RAD LABORATORIES INC.
• BD
• BRUKER
• BGI
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• QIAGEN
• REVVITY
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.